There are currently four known isoforms of nitric oxide synthase (NOS). Of these, neuronal NOS (nNOS) is known to be present exclusively in neurons, endothelial NOS (eNOS) in vascular endothelium, while the inducible form of NOS (iNOS) is known to be activated in oligodendrocytes, astrocytes and microglia. The fourth isoform, mitochondrial NOS (mtNOS), represents a post-translational modification of nNOS. Using western blotting and real time-PCR, we show induction and activation of nNOS following culture of oligodendrocyte progenitor cells (OPC) with lipopolysaccharide (LPS). Activation of nNOS results in accumulation of peroxynitrite and tyrosine nitration of proteins in oligodendrocytes resulting in reduced cell viability. Injection of LPS in vivo into the corpus callosum of rats leads to the development of extensive demyelination of the white matter tracts. Immunostaining of regions close to the injection site shows the presence of nNOS, but not iNOS, in oligodendrocytes. Neither iNOS nor nNOS was seen in astrocytes in areas of demyelination. These studies suggest that activation of nNOS in oligodendrocytes leads to oligodendrocyte injury resulting in demyelination.
Introduction
Oligodendrocytes are the myelin producing cells of the central nervous system (CNS) (Bradl and Lassmann, 2009a; Bradl and Lassmann, 2009b) . Inability of oligodendrocytes to support the integrity of myelin can result from metabolic, infectious and immune causes. Destruction of oligodendrocytes is a central feature of a number of human demyelinating diseases, the most common of which is multiple sclerosis (MS) (Compston and Coles, 2008) .
A number of mutually overlapping mechanisms of oligodendrocyte cell death have been proposed in inflammatory demyelinating diseases of the CNS. Demyelination can occur as a consequence of humoral and cell-mediated cytotoxicity or due to activation of apoptotic pathways induced by local cytokines or due to their susceptibility to excitotoxic death. Cytokines such as tumor necrosis factor (TNF) and gamma interferon (IFN-γ) mediate cell death in oligodendrocytes (Akassoglou et al., 1998) . The development of demyelinating lesions in transgenic mice that over express interleukin 6 (IL-6), TNF-alpha and interleukin-12 (IL-12) and evidence of oligodendrocyte toxicity following direct injection of inflammatory cytokines support a role for cytokinemediated demyelination (Campbell, 1998; Cua et al., 1999; Horwitz et al., 1997) .
More recently, the free radical NO (nitric oxide) is proposed to be an important mediator of oligodendrocyte death (Ghafourifar and Sen, 2007; Smith et al., 2001; Smith and Lassmann, 2002) . NO is produced by the activation of NOS (nitric oxide synthase) and currently four isoforms of NOS are known (Pacher et al., 2007) . Neuronal NOS (nNOS) is constitutively present in neurons and endothelial NOS (eNOS) is present in endothelial cells. The inducible form of NOS (iNOS) is only seen in glial cells, including oligodendrocytes, following stimulation with bacterial cell wall products or cytokines (Giulivi, 2003) . Recently, a fourth isoform of NOS, mitochondrial mtNOS, has been reported. mtNOS is a post-translational modified product of nNOS that is myrisylated and phosphorylated and is localized to the inner membrane of the mitochondria (Ghafourifar and Cadenas, 2005; Haynes et al., 2004; Kanai et al., 2001; Pearce et al., 2002) . At present there are no reagents that will differentiate mtNOS from nNOS and NOS activity in mitochondria is inferred to result from activation of mtNOS. nNOS and eNOS require calcium/calmodulin for activation, while the activity of iNOS is calcium independent. Although by itself nontoxic, NO can be converted to a number of more reactive derivatives, referred to as reactive nitrogen species (RNS) that can impair cellular function. Most importantly, NO can combine with the free radical superoxide, O 2 − , to produce peroxynitrite, which can nitrite or oxidize other molecules. Peroxynitrite accumulation has been thought to play a role in a number of inflammatory and degenerative diseases (Pacher and Szabo, 2008; Radi et al., 2002; Wizemann et al., 1994) .
In inflammatory demyelinating diseases, the presence of NO derived compounds has been recognized. Increased levels of nitrite and nitrate levels in cerebrospinal fluid (CSF) of MS patients have argued for a role of reactive nitrogen species (RNS) in MS (Giovannoni, 1998; Rejdak Journal of Neuroimmunology 229 (2010) 146-156 
